Bielders Loriane Médical: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Bielders Loriane Médical
Largest movements
- Receivables within one year +€22,820
new in 2025: €22,820
of which Other amounts receivable: +€22,523
- Deferred charges and accrued income -€17,680
down €17,680 (-82.8%), from €21,340 to €3,660
- Cash +€11,114
up €11,114 (+8.4%), from €133,104 to €144,218
mainly Net result for the year (+€62,305) and Deferred charges and accrued income (+€17,680)
- Profit (loss) carried forward +€62,305
up €62,305 (+18274.4%), from €341 to €62,646
- Tax, wage and social debts -€33,000
down €33,000 (-99.9%), from €33,045 to €45
of which Taxes: -€30,658
- Other debts -€11,921
down €11,921 (-41.1%), from €28,997 to €17,075
- Gross operating margin -€45,992
down €45,992 (-36.2%), from €127,013 to €81,021
- Taxes -€18,658
down €18,658 (-52.3%), from €35,702 to €17,045
- Depreciation -€2,900
down €2,900 (-100.0%), from €2,900 to €0
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €154,444 | €170,699 | +€16,255 | +10.5% |
| Current assets | 29/58 | €154,444 | €170,699 | +€16,255 | +10.5% |
| Amounts receivable within one year | 40/41 | - | €22,820 | +€22,820 | |
| Trade receivables | 40 | - | €297 | +€297 | |
| Other amounts receivable | 41 | - | €22,523 | +€22,523 | |
| Cash at bank and in hand | 54/58 | €133,104 | €144,218 | +€11,114 | +8.4% |
| Deferred charges and accrued income | 490/1 | €21,340 | €3,660 | -€17,680 | -82.8% |
| Total equity and liabilities | 10/49 | €154,444 | €170,699 | +€16,255 | +10.5% |
| Equity | 10/15 | €90,341 | €152,646 | +€62,305 | +69.0% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €87,000 | €87,000 | = | 0.0% |
| Distributable reserves | 133 | €87,000 | €87,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €341 | €62,646 | +€62,305 | +18274.4% |
| Amounts payable | 17/49 | €64,104 | €18,053 | -€46,050 | -71.8% |
| Amounts payable within one year | 42/48 | €64,104 | €17,909 | -€46,194 | -72.1% |
| Trade debts | 44 | €2,062 | €789 | -€1,273 | -61.7% |
| Suppliers | 440/4 | €2,062 | €789 | -€1,273 | -61.7% |
| Taxes, remuneration and social security | 45 | €33,045 | €45 | -€33,000 | -99.9% |
| Taxes | 450/3 | €30,702 | €45 | -€30,658 | -99.9% |
| Remuneration and social security | 454/9 | €2,342 | €0 | -€2,342 | -100.0% |
| Other amounts payable | 47/48 | €28,997 | €17,075 | -€11,921 | -41.1% |
| Accrued charges and deferred income | 492/3 | - | €144 | +€144 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,900 | €0 | -€2,900 | -100.0% |
| Other operating charges | 640/8 | €203 | €380 | +€176 | +86.6% |
| Gross operating margin | 9900 | €127,013 | €81,021 | -€45,992 | -36.2% |
| Operating profit (loss) | 9901 | €123,910 | €80,641 | -€43,269 | -34.9% |
| Financial income | 75/76B | - | €18 | +€18 | |
| Recurring financial income | 75 | - | €18 | +€18 | |
| Financial charges | 65/66B | €867 | €1,310 | +€443 | +51.1% |
| Recurring financial charges | 65 | €867 | €1,310 | +€443 | +51.1% |
| Profit (loss) for the period before taxes | 9903 | €123,043 | €79,349 | -€43,694 | -35.5% |
| Income taxes | 67/77 | €35,702 | €17,045 | -€18,658 | -52.3% |
| Profit (loss) for the period | 9904 | €87,341 | €62,305 | -€25,036 | -28.7% |
| Profit (loss) for the period to be appropriated | 9905 | €87,341 | €62,305 | -€25,036 | -28.7% |
Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.